fashion -WSS

fashion

author：fashion 2025-10-01 22:48:22 - browse：13

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Life sciences investors close nearly $6 billion in new funds

explore

WSS

New warning issued for rebooking air travel after delays, cancellations

Explaining an after

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Resistance to cancer drugs: A new genetic explanation

How to convince healthy people to buy insurance

Seattle police shoot person suspected in downtown stabbing

hotspot

fashion

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Jerome Adams on the need for new antivirals for Covid

TikTok cracks down on users posting about weight loss drugs

In Memoriam: Notable people who died in 2023

DOJ, FTC to increase scrutiny of all types of health care mergers

Dobbs anniversary: the lost opportunity of abortion as health care

Coloradans with cystic fibrosis could lose access to Trikafta

Tori Bowie and the unacceptable rates of Black maternal death

Prime Medicine says its gene editing passes test in monkeys

leisure time

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Travis Kelce and the trap of celebrity vaccine endorsements

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

How dance can help health care workers heal from trauma

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

explore

Wikipedia

entertainment

leisure time